drugset / Trial / NCT00232349

Efficacy of Galantamine to Treat Schizophrenia

NCT00232349

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study was to determine if treatment with adjunctive galantamine is effective in the reduction of functional impairments in patients with schizophrenia and schizoaffective disorder. It was hypothesized that adjunctive galantamine would yield clinically significant improvements from baseline to end of study on a measure of quality of life and a measure of independent living skills.

Timeline

Start
2005-02
Primary completion
2007-06
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Galantamine Small molecule 12 mg

Indications